Download PDF
Anästhesiol Intensivmed Notfallmed Schmerzther 2016; 10(03): 259-272
DOI: 10.1055/s-0042-107688
Gynäkologische Spezialgebiete und Methoden
Georg Thieme Verlag KG Stuttgart · New York

Multiresistente Erreger – Prävention und Diagnostik

Utz Reichard
,
Renate Rettkowski
,
Simone Scheithauer
Further Information

Publication History

Publication Date:
22 June 2016 (online)

Also available at
    Permissions and Reprints All articles of this category

See also:

Multiresistente Erreger – Prävention und DiagnostikAnästhesiol Intensivmed Notfallmed Schmerzther 2016; 51(02): 112-120
DOI: 10.1055/s-0041-103142

Multiresistente Keime spielen im klinischen Alltag eine zunehmend bedeutsame Rolle, besonders auf Intensivstationen bzw. in Risikobereichen. Oftmals herrschen Unklarheiten bezüglich diagnostischer Screening-Indikationen und Strategien zur Vermeidung von Übertragungen mittels Hygiene- und Isolierungsmaßnahmen. Wir geben einen orientierenden Überblick über die zurzeit gängigen Empfehlungen und bewerten diese für Methicillin-resistente Staphylococcus-aureus-Stämme (MRSA) und multiresistente gramnegative Bakterien (MRGN).

 

  • Literatur

  • 1 Chen LF. The changing epidemiology of methicillin-resistant Staphylococcus aureus: 50 years of a superbug. Am J Infect Control 2013; 41: 448-451
    CrossrefGoogle Scholar
  • 2 GERMAP 2010. Antibiotika-Resistenz und -Verbrauch. Bericht über den Antibiotikaverbrauch und die Verbreitung von Antibiotikaresistenzen in der Human- und Veterinärmedizin in Deutschland. Hrsg.: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg. Rheinbach: Antiinfectives Intelligence Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH; 2011
    Google Scholar
  • 3 RKI. Eigenschaften, Häufigkeit und Verbreitung von MRSA in Deutschland – Update 2013/2014. Epidemiologisches Bulletin 2015; 31: 304-304
    Google Scholar
  • 4 KISS. Im Internet: http://www.nrz-hygiene.de/fileadmin/nrz/module/mrsa/MRSA_Referenzdaten_2014.pdf
    Google Scholar
  • 5 Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592-598
    CrossrefGoogle Scholar
  • 6 Cameron DR, Howden BP, Peleg AY. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 2011; 53: 576-582
    CrossrefGoogle Scholar
  • 7 Yaw LK, Robinson JO, Ho KM. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis 2014; 14: 967-975
    CrossrefGoogle Scholar
  • 8 Bode LG, Kluytmans JA, Wertheim HF et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9-17
    CrossrefGoogle Scholar
  • 9 Fätkenheuer G, Kaasch AJ. How deadly is methicillin-resistant Staphylococcus aureus?. Lancet Infect Dis 2014; 14: 905-907
    CrossrefGoogle Scholar
  • 10 Huang SS, Septimus E, Kleinman K et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255-2265
    CrossrefPubMedGoogle Scholar
  • 11 van Belkum A, Verkaik NJ, de Vogel CP et al. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 2009; 199: 1820-1826
    CrossrefGoogle Scholar
  • 12 Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 1963; 27: 56-71
    Google Scholar
  • 13 RKI. Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcusaureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Epidemiologisches Bulletin 2014; 57: 696-732
    Google Scholar
  • 14 Tacconelli E, De Angelis G, de Waure C et al. Rapid screening tests for methicillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 546-554
    CrossrefGoogle Scholar
  • 15 Farbman L, Avni T, Rubinovitch B et al. Cost-benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review. Clin Microbiol Infect 2013; 19: 582-593
    CrossrefGoogle Scholar
  • 16 McKinnell JA, Huang SS, Eells SJ et al. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013; 34: 161-170
    CrossrefGoogle Scholar
  • 17 Daeschlein G, Assadian O, Daxboeck F et al. Multiplex PCR-ELISA for direct detection of MRSA in nasal swabs advantageous for rapid identification of non-MRSA carriers. Eur J Clin Microbiol Infect Dis 2006; 25: 328-330
    CrossrefGoogle Scholar
  • 18 Holfelder M, Eigner U, Turnwald AM et al. Direct detection of methicillin-resistant Staphylococcus aureus in clinical specimens by a nucleic acid-based hybridisation assay. Clin Microbiol Infect 2006; 12: 1163-1167
    CrossrefGoogle Scholar
  • 19 Gastmeier P, Schwab F, Geffers C et al. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin-resistant Staphylococcus aureus in private rooms in intensive care units. Infect Control Hosp Epidemiol 2004; 25: 109-113
    CrossrefGoogle Scholar
  • 20 Harbarth S, Masuet-Aumatell C, Schrenzel J et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006; 10
    Google Scholar
  • 21 Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect 2010; 74: 204-211
    CrossrefGoogle Scholar
  • 22 Siegel JD, Rhinehart E, Jackson M et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control 2007; 35: 65-164
    Google Scholar
  • 23 Derde LP, Dautzenberg MJ, Bonten MJ. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 2012; 38: 931-939
    CrossrefGoogle Scholar
  • 24 Ridenour G, Lampen R, Federspiel J et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007; 28: 1155-1161
    CrossrefGoogle Scholar
  • 25 Sandri AM, Dalarosa MG, Ruschel de Alcantara L et al. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006; 27: 185-187
    CrossrefGoogle Scholar
  • 26 Ammerlaan HS, Kluytmans JA, Wertheim HF et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009; 48: 922-930
    CrossrefGoogle Scholar
  • 27 Vasquez JE, Walker ES, Franzus BW et al. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans Affairs hospital. Infect Control Hosp Epidemiol 2000; 21: 459-464
    CrossrefGoogle Scholar
  • 28 Harbarth S, Liassine N, Dharan S et al. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31: 1380-1385
    CrossrefGoogle Scholar
  • 29 Kola A, Gastmeier P. Efficacy of oral chlorhexidine in preventing lower respiratory tract infections. Meta-analysis of randomized controlled trials. J Hosp Infect 2007; 66: 207-216
    CrossrefGoogle Scholar
  • 30 Clavero J, Baca P, Junco P et al. Effects of 0.2 % chlorhexidine spray applied once or twice daily on plaque accumulation and gingival inflammation in a geriatric population. J Clin Periodontol 2003; 30: 773-777
    CrossrefGoogle Scholar
  • 31 Russotto V, Cortegiani A, Graziano G et al. Bloodstream infections in intensive care unit patients: distribution and antibiotic resistance of bacteria. Infect Drug Resist 2015; 8: 287-296
    Google Scholar
  • 32 RKI. Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Epidemiologisches Bulletin 2012; 55: 1354
    Google Scholar
  • 33 RKI. Ergänzung zu den „Hygienemaßnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen” (2012) im Rahmen der Anpassung an die epidemiologische Situation. Epidemiologisches Bulletin 2014; 21: 183-184
    Google Scholar
  • 34 Tacconelli E, Cataldo MA, Dancer SJ et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014; 20 (Suppl. 01) 1-55
    Google Scholar
  • 35 Katsandri A, Avlamis A, Vasilakopoulou A et al. Risk factors for coexistence of fluoroquinolone resistance and ESBL production among Enterobacteriaceae in a Greek university hospital. J Chemother 2008; 20: 452-457
    CrossrefGoogle Scholar
  • 36 Walsh F, Rogers TR. Comparison of plasmid-mediated quinolone resistance and extended-spectrum beta-lactamases in third-generation cephalosporin-resistant Enterobacteriaceae from four Irish hospitals. J Med Microbiol 2012; 61: 142-147
    CrossrefGoogle Scholar
  • 37 Witte WM. β-Laktamasen mit breitem Wirkungsspektrum. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2003; 46: 881-890
    CrossrefGoogle Scholar
  • 38 Pages JM, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat Rev Microbiol 2008; 6: 893-903
    CrossrefGoogle Scholar
  • 39 Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clinical microbiology reviews table of contents 2007; 20
    Google Scholar
  • 40 Wiener-Well Y, Rudensky B, Yinnon AM et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010; 74: 344-349
    CrossrefGoogle Scholar
  • 41 Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008; 29: 966-968
    CrossrefGoogle Scholar
  • 42 Doi Y, Onuoha EO, Adams-Haduch JM et al. Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 2011; 49: 154-158
    CrossrefGoogle Scholar
  • 43 Johnson PD, Martin R, Burrell LJ et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005; 183: 509-514
    Google Scholar
  • 44 Borer A, Gilad J, Porat N et al. Impact of 4 % chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect 2007; 67: 149-155
    CrossrefGoogle Scholar
  • 45 Huttner B, Haustein T, Uckay I et al. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013; 68: 2375-2382
    Google Scholar
  • 46 Saidel-Odes L, Polachek H, Peled N et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol 2012; 33: 14-19
    CrossrefGoogle Scholar
  • 47 Strenger V, Gschliesser T, Grisold A et al. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum beta-lactamase-producing enterobacteria in hospitalised newborns. Int J Antimicrob Agents 2011; 37: 67-69
    CrossrefGoogle Scholar
  • 48 Kola A, Holst M, Chaberny IF et al. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007; 66: 46-51
    CrossrefGoogle Scholar
  • 49 Climo MW, Yokoe DS, Warren DK et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368: 533-542
    CrossrefGoogle Scholar
  • 50 Morgan DJ, Pineles L, Shardell M et al. Effect of chlorhexidine bathing and other infection control practices on the Benefits of Universal Glove and Gown (BUGG) trial: a subgroup analysis. Infect Control Hosp Epidemiol 2015; 36: 734-737
    CrossrefGoogle Scholar
  • 51 Viray MA, Morley JC, Coopersmith CM et al. Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection. Infect Control Hosp Epidemiol 2014; 35: 243-250
    CrossrefGoogle Scholar
  • 52 Cassir N, Thomas G, Hraiech S et al. Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control 2015; 43: 640-643
    CrossrefGoogle Scholar
  • 53 Cassir N, Papazian L, Fournier PE et al. Insights into bacterial colonization of intensive care patients skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 2015; 34: 999-1004
    CrossrefGoogle Scholar